Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.14
+0.03 (+0.12%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
2 Top Dividend Stocks to Buy on the Dip
August 16, 2025
These blue chip healthcare stocks could still deliver strong long-term returns.
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
August 16, 2025
Viking Therapeutics' dual-formulation obesity drug could be the David to Lilly's Goliath.
Via
The Motley Fool
Topics
Economy
Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease
August 15, 2025
Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.
Via
Benzinga
3 Long-Term Dividend Buys You Can Get for Under $50
August 15, 2025
Discover three undervalued dividend stocks under $50 that offer income, growth potential, and strong total returns for value investors
Via
MarketBeat
How Do Investors Really Feel About Pfizer?
August 14, 2025
Via
Benzinga
After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?
August 15, 2025
Pfizer beat expectations last quarter and it raised its guidance.
Via
The Motley Fool
Topics
World Trade
Celcuity Expenses Jump 81 Percent
August 14, 2025
Via
The Motley Fool
Cautious Start On Dalal Street As Traders Eye Expiry, WPI Inflation Data; Muthoot Hits Record High, Infosys Gains on Versent Deal
August 14, 2025
Markets watch for the Trump–Putin meeting tomorrow that could impact Russia–Ukraine peace talks. Analysts see 24,600 as a make-or-break level for Nifty ahead of weekly expiry volatility.
Via
Stocktwits
Topics
Economy
Government
Most active S&P500 stocks in Wednesday's session
August 13, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market...
Via
Chartmill
HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week
August 13, 2025
The analyst sees Insmed as "poised to join the ranks" of Roche's Genentech and Pfizer's Seagen as companies that have successfully deployed the "pipeline-in-a-pill" strategy.
Via
Stocktwits
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
August 13, 2025
This big pharma company's juicy dividend is looking even more attractive.
Via
The Motley Fool
Topics
Earnings
Bristol-Myers Squibb’s Q2 Earnings Call: Our Top 5 Analyst Questions
August 13, 2025
Bristol-Myers Squibb’s second quarter saw flat overall sales, but the company surpassed Wall Street expectations for both revenue and non-GAAP profit, with operating margin improving year on year....
Via
StockStory
Topics
Earnings
PFE Q2 Deep Dive: Margin Expansion and R&D Pipeline Fuel Outlook Amid Policy Uncertainty
August 13, 2025
Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $14.65 billion. The company expects the full...
Via
StockStory
Topics
World Trade
The Top 5 Analyst Questions From Pfizer’s Q2 Earnings Call
August 13, 2025
Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for both revenue and non-GAAP earnings. Management attributed this performance...
Via
StockStory
Topics
Earnings
Trading Radar For August 13: Paytm, HUL, Cochin Shipyard, Karnataka Bank, And Jindal Steel Are On Stocks Watchlist
August 12, 2025
BPCL, Pfizer, Vishal Mega Mart, among others, are expected to post their quarterly earnings today.
Via
Stocktwits
Topics
Economy
Energy
Pfizer Raises Its Guidance And Analysts Up Their Targets - PFE Stock Looks Cheap
August 12, 2025
Pfizer, Inc. stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year.
Via
Talk Markets
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
August 12, 2025
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy.
Via
Benzinga
Pfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is Undervalued
August 12, 2025
According to a Bloomberg report, Pfizer has requested that the approval stay in place through the coming fall season.
Via
Stocktwits
Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients
August 12, 2025
Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for cisplatin therapy.
Via
Benzinga
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
August 12, 2025
Dip into a beaten-down market sector for deals on some proven winners.
Via
The Motley Fool
Trading Radar For August 12: Hindalco, Adani Enterprises, Bata, Pfizer, Ashoka Buildcon, And Inox Green Are On Stocks Watchlist
August 11, 2025
Via
Stocktwits
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
August 11, 2025
Investing is about looking ahead.
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
August 11, 2025
It was a rare breath of fresh air for shareholders.
Via
The Motley Fool
Topics
Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Monday's session.
August 11, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via
Chartmill
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today
August 11, 2025
The short-term picture has been less rosy than the longer-term one.
Via
The Motley Fool
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
August 11, 2025
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern on board to fill in gaps.
Via
Benzinga
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
August 11, 2025
Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.
Via
Benzinga
3 Large-Cap Stocks with Promising Prospects
August 11, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
2 Stocks to Buy With $5,000 and Hold for a Decade
August 10, 2025
These two stocks come from completely different industries, but each could boost a long-term investor's returns.
Via
The Motley Fool
2 Beaten-Down Stocks to Buy and Hold
August 10, 2025
The market has been tough on these stocks, but a closer look at each is warranted.
Via
The Motley Fool
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.